BioGaia

BioGaia is a Swedish biotechnology company that develops, markets and sells a range of products with probiotics.

The company owns several commercially important strains and a large number of different patents for commercial usage of Lactobacillus reuteri. BioGaia gut and immune health products contain L. reuteri Protectis (DSM 17938), one of the human L. reuteri strains. BioGaia Probiotics for oral health contain L. reuteri Prodentis, which is a blend of two L. reuteri strains DSM 17938 and ATCC PTA 5289.

Products containing L. reuteri have been proven to be both effective and safe in several areas; infant colic, diarrhoea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults.

The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange.